USFDA promises quick review of Pfizer booster vaccine for all adults

U.S. President Joe Biden's administration in August announced plans to roll out booster doses for all adults in September.

Picture: Pixabay

Last Updated on November 19, 2021 by The Health Master

The U.S. Food and Drug Administration (USFDA) said, it would review Pfizer Inc’s request to authorize booster doses of the C-19 vaccine in all adults “as expeditiously as possible,” with the New York Times reporting that the regulatory nod could come as soon as Thursday.

The agency said it does not plan to hold a meeting of the outside experts on Pfizer’s request, concluding that the request does not raise questions that would benefit from additional discussion by the members of the committee.

The decision by the USFDA will likely come before a U.S. Centers for Disease Control and Prevention (CDC) advisory panel meets on Friday to discuss expanding the eligibility for booster doses of Pfizer/BioNTech’s vaccine, currently allowed for select groups of people.

Earlier this month, Pfizer requested the USFDA to authorize booster doses of the vaccine for all adults, presenting recent data showing the shot would help prevent disease across all ages.

The company’s third dose has been authorized for immunocompromised individuals, people aged 65 and above, all those at high risk of severe disease, and people who are regularly exposed to the virus.

U.S. President Joe Biden’s administration in August announced plans to roll out booster doses for all adults in September.

The CDC sets U.S. adult and childhood immunization schedules based on recommendations from the Advisory Committee on Immunization Practices.

CDSCO gives nod to Cadila for the drug to treat hyperkalemia

Pharma Industry to depend on low cost Chinese APIs due to…

No retention or renewal fees after one time registration of ASU products

PCI issues further advisory to Pharmacy Colleges regarding salaries to Teachers

A woman doing illegal MTPs arrested: Haryana

International Conference on National Education Policy will be held at …

IPC adds new impurities and Reference Standards: Download the list

Drug alert: 36 out of 1061 samples declared as NSQ in October 2021

Latest Circulars by the Govt of India, Dept of Pharmaceuticals, Health…

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner